Trellis Bioscience | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,710 results for “Trellis Bioscience”

Trials

View all 44 →

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

12 participants · First posted Oct 28, 2016

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

6 participants · First posted Jan 29, 2007

Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness

72 participants · First posted May 12, 2017

Drugs

View all 440 →

TRL-7117

TRL-6061

Epoetin alfa biosimilar (Siam Bioscience)

Organizations

View all 269 →

INFLECTIS BIOSCIENCE

France

Lexaria Bioscience

United States

Aytu BioScience

United States

News

View all 957 →

Trellis Bioscience Raises $9 Million Series C to Advance Novel Biofilm-Disrupting Antibody for Prosthetic Joint Infections

eXmoor Pharma and KU Leuven Form Strategic Alliance to Accelerate AAV Gene Therapy Development

Skye Bioscience Advances Nimacimab into Phase 2 Obesity Trial

Page 1 of 171